20298 ⎘
Medicinal preparations containing organic active ingredients; Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin Lactones
Reporter system for high throughput screening of compounds and uses thereof
#1202Paraconic acids as pigmentation activators
#1203Coumarin compounds as receptor modulators with therapeutic utility
#1204COMPOSITIONS AND METHODS FOR TREATING CONDITIONS ASSOCIATED WITH CERAMIDE BIOSYNTHESIS
#1205Site-activated binding systems that selectively increase the bioactivity of phenolic compounds at target sites
#1206Color Cosmetic
#1207METHOD FOR INHIBITING THE GROWTH OF CANCER STEM CELLS
#1208SYNERGISTIC ANTIBIOTIC COMBINATIONS AND DERIVATIVES
#1209PHARMACEUTICAL COMPOSITION INCLUDING SUNFLOWER EXTRACT, PREPARATIVE METHOD AND USE THEREOF
#1210CHRONIC INFLAMMATION AND TRANSPLANTATION
#1211Methods to accelerate tissue and wound healing rates and reduce swelling and scar formation
#1212TREATMENT OF COPD, GASTRO-ESOPHAGEAL REFLUX DISEASE (GERD), FOOD ALLERGIES AND OTHER GASTROINTESTINAL CONDITIONS AND DISORDERS AMELIORATED BY PROPER HISTAMINE MANAGEMENT USING A COMBINATION OF HISTIDINE DECARBOXYLASE INHIBATORS, LRA DRUGS, ANTI-H1 AND/OR ANTI-H2 DRUGS
#1213Pharmaceutical composition with anti-obesity activity comprising a premixture of pure orlistat and preparation process
#1214Protein synthesis required for long-term memory is induced by PKC activation on days preceding associative learning
#1215Edible energy composition
#1216METHODS FOR TREATING OR PREVENTING ALCOHOL-RELATED DISORDERS OR CRAVING-RELATED DISORDERS
#1217Combination of local and systemic immunomodulative therapies for enhanced treatment of cancer
#1218USE OF A SPIROLIDE, ANALOGUES AND DERIVATIVES FOR TREATING AND/OR PREVENTING PATHOLOGICAL CONDITIONS LINKED TO THE TAU AND BETA-AMYLOID PROTEINS
#1219PACKAGE AND METHOD OF MARKETING
#1220Drug delivery from rapid gelling polymer composition
#1221Inhibiting GS-FDH to Modulate No Bioactivity
#1222Pharmaceutical Compositions Comprising Mycophenolic Acid or Mycophenolate Salt
#1223FGFR1 extracellular domain combination therapies for lung cancer
#1224Synthetic lactone formulations and method of use
#1225Method for producing triptolide
#1226Inclusion complex of deoxypodophyllotoxin of cyclodextrin, preparation method, use for treatment of cancer thereof
#1227USE OF MACROCYCLIC LACTONE DERIVATIVES FOR THE TREATMENT OF INFLAMMATORY DISORDERS
#1228Rapamycin Derivative or an Impdh Inhibitor for Treating Polycystic Kidney Disease
#1229Ophthalmic drug delivery system and method
#1230Method for inhibiting blood vessel stenosis
#1231Methods, compounds, and compositions for delivering 1,3-propanedisulfonic acid
#1232TOFA analogs useful in treating dermatological disorders or conditions
#1233Avermectins and milbemycins for the treatment, prevention or amelioration of flavivirus infections
#1234PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT/PROPHYLAXIS OF NON-ALCOHOLIC FATTY LIVER DISEASE
#1235Extracts, fractions and compositions comprising acetogenins and their applications
#1236TREATMENT OF MULTIPLE SCLEROSIS
#1237Therapeutic Inhibitor of Vascular Smooth Muscle Cells
#1238Methods and compositions for heavy metal detoxification
#1239Method for treatment of diarrhea-predominant irritable bowel syndrome
#1240N alkylcarbonyl amino lactone compounds and their use
#1241IMMUNOSTIMULANT
#1242INFLAMMATORY EYE DISEASE
#1243COMBINATIONS OF HMG-COA REDUCTASE INHIBITORS AND NICOTINIC ACID COMPOUNDS AND METHODS FOR TREATING HYPERLIPIDEMIA ONCE A DAY AT NIGHT
#1244NOVEL MONASCUSPURPURONES, PREPARATION PROCESS THEREOF, AND USES OF THE MONASCUSPURPURONES
#1245Methods for improving cognitive function
#1246TREATMENT AND PREVENTION OF SECONDARY INJURY AFTER TRAUMA OR DAMAGE TO THE CENTRAL NERVOUS SYSTEM
#124711 beta, 13-DIHYDROHELENALIN DERIVATIVES AND USES THEREOF AS BOMBESIN RECEPTOR SUBTYPE 3 AGNOISTS
#1248Method of treating neurogenic overactive bladder in a mammal or method of treating non-psychological stress-related bladder dysfunction in a female mammal by administering at least on jasmonate
#1249IMMUNOLOGIC COMPOUNDS FOR PREVENTION, PROTECTION, PROPHYLAXIS OR TREATMENT OF IMMUNOLOGICAL DISORDERS, INFECTIONS AND CANCER
#1250Covalent inhibition of bacterial quorum sensing
#1251Edible energy composition
#1252Compositions and methods for enhancing virus efficacy
#1253Polymer conjugate of bioactive substance having hydroxy group
#1254METHODS AND COMPOSITIONS RELATED TO SYNERGISTIC RESPONSES TO ONCOGENIC MUTATIONS
#1255Lipoxin analogs and methods for the treatment of periodontal disease
#1256Antrocin containing pharmaceutical compositions for inhibiting cancer cells
#1257Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation
#1258Plant extract comprising statins and preparation techniques and uses thereof
#1259PRESERVATIVE-FREE PHARMACEUTICAL TETRAHYDROLIPSTATIN COMPOSITIONS
#1260Anti-inflammatory composition containing macrolactin A and a derivative thereof as active ingredients
#1261Therapeutic compositions
#1262Topical parasiticide composition
#1263Animal Treatment
#1264Apparatus and Method for Reducing the Occurrence of Post-Surgical Adhesions
#1265MILBEMYCIN COMPOUNDS AND TREATMENT OF DERMATOLOGICAL DISORDERS IN HUMANS THEREWITH
#1266Fibrate-statin Combinations with Reduced Fed-fasted Effects
#1267Methods and systems for modulating hormones and related methods, agents and compositions
#1268Soft capsule of butylphthalide and a process for preparing the same
#1269Macrocyclic lactone drug delivery system
#1270Palatable ductile chewable veterinary composition
#1271MOLECULAR ACTIVATORS OF THE WNT/BETA-CATENIN PATHWAY
#1272COMBINATION OF A TLR3 LIGAND AND A CHEMOTHERAPY AGENT WHICH ACTS ON THE INTRINSIC "APOPTOSIS" PATHWAY IN THE TREATMENT OF CANCER
#1273Use of deoxyelephantopin (DET) and analogues thereof for treatment of melanoma
#1274METHOD OF TREATMENT OF PREMALIGNANT AND MALIGNANT SKIN LESIONS WITH CYTOTOXIC AGENTS
#1275POLY(GLUTAMIC ACID)-DRUG CONJUGATE WITH AN AMINO ACID AS A LINKER
#1276Burdock fruit extract containing arctigenin at high content and process for producing same
#1277Method of treating lupus nephritis
#1278USE OF ANDROGRAPHOLIDE COMPOUNDS FOR TREATING INFLAMMATION AND AIRWAY DISORDERS
#1279Use of artemisinin for treating tumors induced by oncogenic viruses and for treating viral infections
#1280AVERMECTIN COMPOUNDS AND TREATMENT OF DERMATOLOGICAL DISORDERS IN HUMANS THEREWITH
#1281COMBINATION THERAPIES WITH COX-2 INHIBITORS AND TREPROSTINIL
#1282Pharmaceutical composition with immunomodulating function
#1283Composition Having Anti-Helicobacter Pylori Activity And Its Application To Inhibit Helicobacter Pylori
#1284Lipase inhibiting composition
#1285SIGMA RECEPTORS LIGANDS WITH ANTI-APOPTOTIC AND/OR PRO-APOPTOTIC PROPERTIES, OVER CELLULAR MECHANISMS, EXHIBITING PROTOTYPICAL CYTOPROTECTIVE AND ALSO ANTICANCER ACTIVITY
#1286Flaxseed lignan complex and its use thereof
#1287Therapeutic Inhibitor of Vascular Smooth Muscle Cells
#1288Butylphthalide intravenous emulsion and application thereof
#1289TREATMENT OF DEPRESSIVE DISORDERS
#1290Tautomycetin and tautomycetin analog biosynthesis
#1291INJECTABLE PARASITICIDAL FORMULATIONS OF LEVAMISOLE AND MACROCYCLIC LACTONES
#1292Migrastatin analogs and uses thereof
#1293COMBINATIONS COMPRISING A PROTEIN KINASE INHIBITOR BEING A PYRIMIDYLAMINOBENZAMIDE COMPOUND AND A HSP90 INHIBITOR SUCH AS 17-AAG
#1294Composition from Sphaeranthus indicus and Garcinia mangostana for the control of metabolic syndrome
#1295Generation of virus-like particles and use as panfilovirus vaccine
#1296Pharmaceutical Compositions Containing Lipase Inhibitors
#1297COMPOSITIONS AND METHODS FOR TREATING VASCULAR, AUTOIMMUNE, AND INFLAMMATORY DISEASES
#1298Compositions that include anthocyanidins and methods of use
#1299Migrastatin analog compositions and uses thereof
#1300Screen for inhibitors of filovirus and uses therefor
#1301MOLECULAR MODULATORS OF THE WNT/BETA-CATENIN PATHWAY
#1302Methods for Alzheimer's Disease Treatment and Cognitive Enhancement
#1303Parasiticidal compositions comprising multiple active agents, methods and uses thereof
#1304Methods to prevent and treat diseases
#1305Controlled releasing composition
#1306Composition for the prevention and treatment of absence seizures comprising PKC agonist as an effective ingredient
#1307COMPOSITIONS OF A V-ATPASE INHIBITOR IN COMBINATION WITH A GLUCOCORTICOID RECEPTOR LIGAND AND METHODS OF USE
#1308Extended release compositions comprising mycophenolate sodium and processes thereof
#1309COMPOSITIONS AND METHODS FOR TISSUE REPAIR
#1310Synthesis of resorcylic acid lactones useful as therapeutic agents
#1311Modulation of bacterial quorum sensing with synthetic ligands
#1312PCK ACTIVATION AS A MEANS FOR ENHANCING sAPPa SECRETION AND IMPROVING COGNITION USING BRYOSTATIN TYPE COMPOUNDS
#1313Ursolic acid derivative and pharmaceutical composition thereof
#1314Compounds and compositions useful in the treatment of malaria
#1315COMPOUNDS FOR CANCER THERAPY
#1316USE OF CYCLOLIGNANS FOR THE TREATMENT OF A HYPERACTIVE IMMUNE SYSTEM
#1317Compositions comprising macrocyclic lactone compounds and spirodioxepinoindoles
#1318COMPOSITIONS AND METHODS FOR MUCOSITIS AND ONCOLOGY THERAPIES
#1319Antiparisitic dihydroazole compounds and compositions comprising same
#1320ANTHELMINTIC COMPOSITIONS
#1321Combinations of immunosuppressive agents for the treatment or prevention of graft rejections
#1322Rapamycin Derivative or an Impdh Inhibitor for Treating Polycystic Kidney Disease
#1323Use of COX-2 Inhibitors for the Treatment of Schizophrenia, Delusional Disorders, Affective Disorders, Autism or Tic Disorders
#1324OPHTHALMIC DRUG DELIVERY SYSTEM AND METHOD
#1325ANTI-CANCER ACTIVE SUBSTANCE FROM ANTRODIA CAMPHORATA, METHOD FOR PREPARING THE SAME AND USE THEREOF
#1326NATURAL BIOACTIVE COMPOUNDS
#1327TREATMENT Of RINGWORM
#1328Wound and skin care compositions
#1329COMPOSITIONS COMPRISING ADJUVANT, MACROLIDE AND PROTEINACEOUS ANTIGEN AND METHODS OF USE THEREOF
#1330Treatment of malaria
#1331TRIPTOLIDE DERIVATIVES FOR MODULATION OF APOPTOSIS AND IMMUNOSUPPRESSION
#1332Lipoxin analogs and methods for the treatment of periodontal disease
#1333DNA DAMAGING AGENTS IN COMBINATION WITH TYROSINE KINASE INHIBITORS
#1334Skin Circulation-Improving Agent And Skin Temperature-Elevating Agent
#1335Cancer chemotherapy compositions comprising PI3K pathway modulators and triptolide
#1336PROCESS FOR OBTAINING POWDER COMPOSITIONS OF ORLISTAT
#1337Long Acting Injectable Formulations
#1338Enhanced ocular neuroprotection and neurostimulation
#1339Pharmaceutical composition effective against biofilms
#1340Pharmaceutical composition
#1341Protective compositions for dermal papilla cells
#1342COMBINATION OF EPOTHILONE ANALOGS AND CHEMOTHERAPEUTIC AGENTS FOR THE TREATMENT OF PROLIFERATIVE DISEASES
#1343Polymeric compositions comprising therapeutic agents in crystalline phases, and methods of forming the same
#1344Methods for Alzheimer's Disease treatment and cognitive enhancement
#1345Stimulating Neuronal Growth Using Brevetoxins
#1346METHODS FOR TREATING STRESS INDUCED EMOTIONAL DISORDERS
#1347MODIFIED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING MYCOPHENOLATE AND PROCESSES THEREOF
#1348Treatment of Autoimmune Diseases
#1349Treatment of vasculitis
#1350Treatment of Autoimmune Diseases
#1351Compositions and methods which modulate G-protein signaling for the treatment of inflammatory disorders such as asthma and allergic conjunctivitis
#1352Treatment of Autoimmune Diseases
#1353PHARMACEUTICAL COMPOSITION OF ORLISTAT
#1354Inhibitors of NAAA and Methods Thereof
#1355COMPOSITION USEFUL FOR THE PREVENTION OF ADVERSE EFFECT DUE TO THE USE OF PPAR-GAMMA AGONISTS
#1356TUBEROUS SCLEROSIS TREATMENT
#1357NOVEL COMPOSITION TO INCREASE TESTOSTERONE LEVELS
#1358PROTEIN SYNTHESIS REQUIRED FOR LONG-TERM MEMORY IS INDUCED BY PKC ACTIVATION ON DAYS PRECEDING ASSOCIATIVE LEARNING
#1359Ketone bodies and ketone body esters as blood lipid lowering agents
#1360Biologically active macrolides, compositions, and uses thereof
#1361Treatment of neurofibromatosis with radicicol and its derivatives
#1362Methods of treatment using combination therapy
#1363Compositions and methods for drug delivery
#1364USE OF INHIBITORS OF SOLUBLE EPOXIDE HYDROLASE TO SYNERGIZE ACTIVITY OF COX AND 5-LOX INHIBITORS
#1365Method of treating pain caused by inflammation
#1366Method of inhibiting inflammatory pain
#1367Combination of selected analgesics and COX-II inhibitors
#1368Reagents and methods for cancer treatment and prevention
#1369Macrocyclic lactone combination compositions, vaccines and methods for producing same
#1370Use of azaphilone compounds for the modulation of the activity of a nuclear hormone receptor
#1371Methods of treating skin with aromatic skin-active ingredients
#1372PREVENTIVE/REMEDY FOR URINARY CALCULOSIS
#1373STREPTOMYCES-DERIVED ANTIMICROBIAL COMPOUND AND METHOD OF USING SAME AGAINST ANTIBIOTIC-RESISTANT BACTERIA
#1374USE OF CYCLOLIGNANS FOR THE TREATMENT OF TYPE 2 DIABETES AND AS CONTRACEPTIVES
#1375PHARMACEUTICAL COMPOSITIONS FOR ORAL USE FOR TREATING PATIENTS AFFECTED BY OBESITY
#1376NEW USE OF SPECIFIC CYKLOLIGNANS
#1377PHARMACEUTICAL COMPOSITIONS COMPRISING MYCOPHENOLIC ACID OR MYCOPHENOLATE SALT
#1378Color cosmetic
#1379Orlistat compositions
#1380Anthelmintic combination
#1381ORLISTAT PHARMACEUTICAL FORMULATIONS
#1382METHODS FOR THE PREVENTION OR TREATMENT OF BACTERIAL AND FUNGAL INFECTIONS
#1383Method and Composition for Treating Alzheimer's Disease and Dementias of Vascular Origin
#1384Method to maintain the efficacy of orlistat
#1385Treatment of Conditions Related to Shock
#1386METHOD FOR IN SITU SOLIDIFICATION OF BLOOD-POLYMER COMPOSITIONS FOR REGENERATIVE MEDICINE AND CARTILAGE REPAIR APPLICATIONS
#1387Method for the asymmetric synthesis of beta-lactone compounds
#1388OIL-BASED NSAID COMPOSITIONS AND METHODS FOR MAKING AND USING SAME
#1389Method and Composition for Treating Alzheimer's Disease and Dementias of Vascular Origin
#1390Chronic inflammation and transplantation
#1391Genipin derivatives and uses thereof
#1392Small molecule antagonists of bacterial quorum-sensing receptors
#1393NOVEL COMBINED ADMINISTRATION
#1394ANALGESIC COMPOSITION OF TOPICALLY APPLIED NONSTEROIDAL ANTIINFLAMMATORY DRUGS AND OPIOIDS
#1395Generation of virus-like particles and use as panfilovirus vaccines
#1396PODOPHYLLOTOXIN INHIBITORS OF TOPOISOMERASE II
#1397Prevention of Cancers by Immunization
#1398Prolongation of Survival of an Allograft by Inhibiting Complement Activity
#1399MICROORGANISM-KILLING COMBINATION
#1400METHOD OF INDUCING NEGATIVE CHEMOTAXIS USING AN ELLAGITANNIN OR GALLOTANNIN
#1401OPHTHALMIC DRUG DELIVERY SYSTEM AND METHOD
#1402COMBINATION THERAPIES FOR THE TREATMENT OF OBESITY
#1403COMBINATION THERAPIES FOR THE TREATMENT OF OBESITY
#1404USE OF SERUM AMYLOID A GENE IN DIAGNOSIS AND TREATMENT OF GLAUCOMA AND IDENTIFICATION OF ANTI-GLAUCOMA AGENTS
#1405Dietary and pharmaceutical compositions containing tricyclic diterpenes and their derivates and their uses
#1406Preservative System for Emulsion-Based Therapeutic Topical Formulations
#1407Benzimidazole anthelmintic compositions
#1408COMPOSITIONS AND METHODS FOR TREATING CONDITIONS ASSOCIATED WITH CERAMIDE BIOSYNTHESIS
#1409Use of cis-epoxyeicosatrienoic acids and inhibitors of soluble epoxide hydrolase to treat conditions mediated by PBR, CB2, and NK2 receptors
#1410SIGMA(s)-RECEPTOR LIGANDS WITH ANTI-APOPTOTIC AND/OR PRO-APOPTOTIC PROPERTIES OVER CELLULAR BIOCHEMICAL MECHANISMS, WITH NEUROPROTECTIVE, ANTI-CANCER, ANTI-METASTATIC AND ANTI-(CHRONIC) INFLAMMATORY ACTION
#1411COMPOSITIONS AND METHODS FOR MODULATING POLY(ADP-RIBOSE) POLYMERASE ACTIVITY
#1412Anti-cholesterolemic compounds and methods of use
#1413Cytotoxin Compound And Method of Isolation
#1414USE OF SERUM AMYLOID A GENE IN DIAGNOSIS AND TREATMENT OF GLAUCOMA AND IDENTIFICATION OF ANTI-GLAUCOMA AGENTS
#1415Dietary and pharmaceutical compositions containing carnosol and/or rosmanol and their uses
#1416Compounds and Compositions for Use in the Prevention and Treatment of Disorders of Fat Metabolism and Obesity
#1417Pharmaceutical composition combining tenatoprazole and an anti-inflammatory agent
#1418Pyrrolo[2,3-D]pyrimidine compounds
#1419Methods for Alzheimer's disease treatment and cognitive enhancement
#1420Methods of Inducing Weight Loss
#1421Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases
#1422Inhibiting GS-FDH to modulate no bioactivity
#1423FORMULATIONS FOR TREATING EYE DISORDERS
#1424Anti-tumor effect of dimeric phthalide compound
#1425Pharmaceutical compositions and methods for peptide treatment
#1426SPECIFIC KINASE INHIBITORS
#1427Small Compounds That Correct Protein Misfolding and Uses Thereof
#1428Use of specific cyklolignans
#1429TRANSDERMAL AND TOPICAL ADMINISTRATION OF DRUGS USING BASIC PERMEATION ENHANCERS
#1430Edible energy composition
#1431Lipoxin analogs and methods for the treatment of periodontal disease
#1432SELECTIVE INHIBITORS FOR TRANSFERASES
#1433Methods and compositions for treating nephrogenic diabetes and insipidus
#1434Neuronal circuit-dependent neuroprotection by interaction between nicotinic receptors
#1435Butylphthalide Intravenous Emulsion and Application Thereof
#1436INHIBITORY EFFECTS OF NORDIHYDROGUAIARETIC ACID (NDGA) ON THE IGF-1 RECEPTOR AND ANDROGEN DEPENDENT GROWTH OF LAPC-4 PROSTATE CANCER CELLS
#1437Migraine tonic
#1438Milbemycin compounds and treatment of dermatological disorders in humans therewith
#1439Milbemycin compounds and treatment of dermatological disorders in humans therewith
#1440Therapeutic compositions
#1441Pharmaceutical formulation
#1442Method of treating dyslipidemia using naturally occurring diterpene
#1443Pharmaceutical composition
#1444Treatment of viral infections by modulation of host cell metabolic pathways
#1445PHARMACEUTICAL COMPOSITION CONTAINING LIPOPHILIC SUBSTANCE WHICH INHIBITS IL-2 PRODUCTION
#1446TARGET MOLECULES OF PLADIENOLIDES, COMPOUNDS BINDING TO SUCH TARGET MOLECULES, AND SCREENING METHOD THEREOF
#1447(MONITORING ONLY) COMBINATIONS OF HMG-COA REDUCTASE INHIBITORS AND NICOTINIC ACID COMPOUNDS AND METHODS FOR TREATING HYPELIPIDEMIA ONCE A DAY AT NIGHT
#1448Tumor necrosis factor inhibitors
#1449Compositions comprising apocynin, ginkgo and ginger and uses thereof
#1450Treatment of Sexual Dysfunction with Proton Pump Agonists
#1451Composition and methods for weight loss in a subject
#1452Treatment regimen for N-MYC, c-MYC, and L-MYC amplified and overexpressed tumors
#1453Vaginal health products
#1454Hedgehog pathway antagonists to treat disease
#1455Antibiotic compositions and related screening methods
#1456Pharmaceutical composition for the treatment of otomycosis
#1457Treatment of erectile dysfunction and libido enhancement
#1458METHODS OF TREATING SKIN WITH AROMATIC SKIN-ACTIVE INGREDIENTS
#1459TRANSDERMAL AND TOPICAL ADMINISTRATION OF DRUGS USING BASIC PERMEATION ENHANCERS
#1460Cytotoxin compounds and methods of isolation
#1461DRUG DELIVERY FROM RAPID GELLING POLYMER COMPOSITION
#1462Cholesterol lowering supplement and low cholesterol egg produced by using the same
#1463Measuring the distance between devices
#1464Triptolide derivatives for modulation of apoptosis and immunosuppression
#1465Methods for prognosing the ability of a zearalenone analog compound to treat cancer
#1466USE OF SUGAR PHOSPHATES, SUGAR PHOSPHATE ANALOGS, AMINO ACIDS AND/OR AMINO ACID ANALOGS FOR MODULATING THE GLUCOLYSIS-ENZYME COMPLEX, THE MALATE ASPARATE SHUTTLE AND/OR THE TRANSAMINASES
#1467High-molecular weight conjugate of podophyllotoxins
#1468Phosphodiesterase 10 Inhibition as Treatment for Obesity-Related and Metabolic Syndrome-Related Conditions
#1469METHOD OF TREATING ASTHMA, ALLERGIC RHINITIS, AND SKIN DISORDERS
#1470Compositions and Methods for Treatment and Prevention of Metabolic Syndrome and its Associated Conditions with Combinations of Flavonoids, Liminoids and Tocotrienols
#1471Methods and compositions for heavy metal detoxification
#1472CHEMICAL COMPOSITION DERIVED FROM P-HYDROXYPHENYL PROPIONIC ACID FOR THE TREATMENT OF PSORIASIS
#1473USE OF INHIBITORS OF THE CELLULAR NA+/H+ EXCHANGER (NHE) FOR PREPARING A MEDICAMENT FOR NORMALIZING SERUM LIPIDS
#1474ENHANCED RECOVERY FOLLOWING OCULAR SURGERY
#1475NOVEL NON-SELECTIVE CATION CHANNEL IN NEURONAL CELLS AND METHOD FOR TREATING BRAIN SWELLING
#1476Stimulation Of CPT-1 As A Means To Reduce Weight
#1477Migrastatin analogs in the treatment of cancer
#1478Method for treatment of chronic neuropathic pain
#1479Statin-carboxyalkylether combinations
#1480extract
#1481ANDROGRAPHIS PANICULATA EXTRACT
#1482Film delivery system for tetrahydrolipstatin
#1483DIETARY AND PHARMACEUTICAL COMPOSITIONS CONTAINING TRICYCLIC DITERPENES AND THEIR DERIVATIVES AND THEIR USES
#1484Treatment of vascular, autoimmune and inflammatory diseases using low dosages of IMPDH inhibitors
#1485TREATING PROSTATE CANCER WITH ANTI-ErbB2 ANTIBODIES
#1486COMPOUNDS FROM MYROTHECIUM SP. FOR INHIBITING THE GROWTH OF CANCER CELLS
#1487Multikinase inhibitors for use in the treatment of cancer
#1488COMBINATION OF AN IMMUNOSUPPRESSANT AND A PPAR GAMMA AGONIST FOR THE TREATMENT OF AN UNDESIRABLE IMMUNE RESPONSE
#1489Growth stimulant compositions
#1490Veterinarian composition comprising an organic salt of levamisole in combination with at least one avermectin and/or milbemycin
#1491Pharmaceutical composition comprising lipase inhibitor and lipophilic oil absorbent and oral formulation prepared therefrom
#1492Drug combinations comprising (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-YL](3R,5S)-3, 5-dihydroxyhept-6-enoic acid and an inhibitor, inducer or substrate of P450 isoenzyme 3A4
#1493Treatment of Depressive Disorders
#1494Therapeutic effects of Bryostatins, Bryologs, and other related substances on Ischemia/stroke-induced memory impairment and brain injury
#1495ENDOPARASITICIDAL TOPICAL COMPOSITIONS
#1496METHOD OF ADMINISTRATION
#1497Tacrolimus Combination Products
#1498Pharmaceutical composition and health food comprising extract of sp. PL3 or phellinsin A isolated from the same as an effective component for prevention and treatment of cardiovascular disease
#1499V-Atpase Inhibitors of Use in the Treatment of Septic Shock
#1500Modulation of bacterial quorum sensing with synthetic ligands